Cheratussin AC

Product NDC: 50090-0423
11-digit product format: 500900423
Labeler code: 50090
Product ID: 50090-0423_93690d90-f18d-44e6-bbab-1955f9d3e646
Type: HUMAN OTC DRUG
Nonproprietary name: codeine phosphate and guaifenesin
Dosage form: LIQUID
Route: ORAL
Labeler: A-S Medication Solutions
Application: part341
Marketing category: OTC MONOGRAPH FINAL
Marketing start: 1996-09-01
Marketing end: 0000-00-00
Substance: CODEINE PHOSPHATE; GUAIFENESIN
Active strength: 10 mg/5mL; mg/5mL
DEA schedule: CV
NDC exclude flag: No
Listing certified through: 2020-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	50090-0423		I	Inactivated by FDA		2026-10-16
excluded package	package	50090-0423	50090-0423-0	I	Inactivated by FDA		2026-10-16

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 30 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	50090-0423-0	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	50090-0423-0	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	50090-0423-0	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	50090-0423-0	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	50090-0423-0	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	50090-0423-0	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	50090-0423-0	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	50090-0423-0	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	50090-0423-0	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	50090-0423-0	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	50090-0423-0	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	50090-0423-0	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	50090-0423-0	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	50090-0423-0	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	50090-0423-0	`1332a3947898…`	`d4bfe170f9cd…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
41b814f3-0166-1c53-c9ef-a0794c7daf9d	Product name	3	20221110
a590be26-846c-8659-a5a1-fb25907965dc	Product name	2	20221110
09d8330d-4fec-be98-3a66-f985140646b2	Product name	2	20210513
20c8cafe-5cfc-44f8-a9be-a664f437f780	Product name	2	20200225
182f9ab4-4ab5-c449-200f-87ce2ce8e550	Product name	2	20151105
e0b6c8be-f2bd-9f86-a9fc-3ed56ffaa814	Product name	3	20150910
c6fba691-a132-4ede-95c6-f8c6bd696636	Product name	1	20150902
c0200ab5-4954-454e-9676-30b741b245bd	Product name	1	20150730
4fe95224-f543-4dbb-9445-8cca122b48c8	Product name	1	20150609
e8718272-64cb-4436-969b-176c3067c8f4	Product name	1	20150609
106ff02a-57e1-4c4c-a307-fd582ff4e311	Product name	1	20150212
e9576821-a971-5261-628e-82ad9e10acdb	Product name	2	20150121
2a21311a-89e2-0e83-2ebd-117f9798b2b2	Product name	1	20140508
30c51294-7ae9-8007-7de6-58222684a0be	Product name	1	20140508
47fd879b-91c5-e1e5-130f-29d082a871ec	Product name	1	20140508
c35d1ac8-8885-2ee1-6c52-5a715b242c00	Product name	1	20140508
ce055423-1d7f-3c41-dff1-83660fa8cd96	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
50090-0423-0	2023-01-30	C162847	48780-1	f386c64a-473f-0266-e053-dadaa90a7c1a	4c76c664-a999-4b6a-b4e2-5634e8539639

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
50090-0423-0	Cheratussin AC	118 mL in 1 BOTTLE, PLASTIC	LIQUID	118		10

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
50090-0423-0	ML - Milliliter	50090-0423	2ce284f2-81c7-4dc3-a427-876adbf850cb	1	2018-09-05

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
CODEINE PHOSPHATE	ACTIVE INGREDIENT	GSL05Y1MN6	CHERATUSSIN AC (CODEINE PHOSPHATE AND GUAIFENESIN) LIQUID [A-S MEDICATION SOLUTIONS LLC]	1
GUAIFENESIN	ACTIVE INGREDIENT	495W7451VQ	CHERATUSSIN AC (CODEINE PHOSPHATE AND GUAIFENESIN) LIQUID [A-S MEDICATION SOLUTIONS LLC]	1
CODEINE ANHYDROUS	ACTIVE MOIETY	UX6OWY2V7J	CHERATUSSIN AC (CODEINE PHOSPHATE AND GUAIFENESIN) LIQUID [A-S MEDICATION SOLUTIONS LLC]	1
GUAIFENESIN	ACTIVE MOIETY	495W7451VQ	CHERATUSSIN AC (CODEINE PHOSPHATE AND GUAIFENESIN) LIQUID [A-S MEDICATION SOLUTIONS LLC]	1
ALCOHOL	INACTIVE INGREDIENT	3K9958V90M	CHERATUSSIN AC (CODEINE PHOSPHATE AND GUAIFENESIN) LIQUID [A-S MEDICATION SOLUTIONS LLC]	1
ANHYDROUS CITRIC ACID	INACTIVE INGREDIENT	XF417D3PSL	CHERATUSSIN AC (CODEINE PHOSPHATE AND GUAIFENESIN) LIQUID [A-S MEDICATION SOLUTIONS LLC]	1
CARAMEL	INACTIVE INGREDIENT	T9D99G2B1R	CHERATUSSIN AC (CODEINE PHOSPHATE AND GUAIFENESIN) LIQUID [A-S MEDICATION SOLUTIONS LLC]	1
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	CHERATUSSIN AC (CODEINE PHOSPHATE AND GUAIFENESIN) LIQUID [A-S MEDICATION SOLUTIONS LLC]	1
GLYCERIN	INACTIVE INGREDIENT	PDC6A3C0OX	CHERATUSSIN AC (CODEINE PHOSPHATE AND GUAIFENESIN) LIQUID [A-S MEDICATION SOLUTIONS LLC]	1
MENTHOL	INACTIVE INGREDIENT	L7T10EIP3A	CHERATUSSIN AC (CODEINE PHOSPHATE AND GUAIFENESIN) LIQUID [A-S MEDICATION SOLUTIONS LLC]	1
SACCHARIN SODIUM	INACTIVE INGREDIENT	SB8ZUX40TY	CHERATUSSIN AC (CODEINE PHOSPHATE AND GUAIFENESIN) LIQUID [A-S MEDICATION SOLUTIONS LLC]	1
SODIUM BENZOATE	INACTIVE INGREDIENT	OJ245FE5EU	CHERATUSSIN AC (CODEINE PHOSPHATE AND GUAIFENESIN) LIQUID [A-S MEDICATION SOLUTIONS LLC]	1
SORBITOL	INACTIVE INGREDIENT	506T60A25R	CHERATUSSIN AC (CODEINE PHOSPHATE AND GUAIFENESIN) LIQUID [A-S MEDICATION SOLUTIONS LLC]	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	CHERATUSSIN AC (CODEINE PHOSPHATE AND GUAIFENESIN) LIQUID [A-S MEDICATION SOLUTIONS LLC]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
50090-0423	CHERATUSSIN AC (CODEINE PHOSPHATE AND GUAIFENESIN) LIQUID [A-S MEDICATION SOLUTIONS]	10	Legacy NDC, 1 package rows	20190225_4c76c664-a999-4b6a-b4e2-5634e8539639.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
GSL05Y1MN6	CODEINE PHOSPHATE	41444-62-6	CODEINE PHOSPHATE
495W7451VQ	GUAIFENESIN	93-14-1	GUAIFENESIN

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
995872	Cheratussin AC 10 MG / 100 MG in 5 mL Oral Solution	PSN	4c76c664-a999-4b6a-b4e2-5634e8539639	10
995868	codeine phosphate 10 MG / guaiFENesin 100 MG in 5 mL Oral Solution	PSN	4c76c664-a999-4b6a-b4e2-5634e8539639	10
995872	codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML Oral Solution [Cheratussin]	SBD	4c76c664-a999-4b6a-b4e2-5634e8539639	10
995868	codeine phosphate 2 MG/ML / guaifenesin 20 MG/ML Oral Solution	SCD	4c76c664-a999-4b6a-b4e2-5634e8539639	10
995872	Cheratussin AC (codeine phosphate 10 MG / guaifenesin 100 MG) per 5 ML Oral Solution	SY	4c76c664-a999-4b6a-b4e2-5634e8539639	10
995868	codeine phosphate 10 MG / guaifenesin 100 MG per 5 ML Oral Solution	SY	4c76c664-a999-4b6a-b4e2-5634e8539639	10

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
50090-0423-0	50090042300	118 mL in 1 BOTTLE, PLASTIC (50090-0423-0)	118 ml	2014-11-28	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Cheratussin AC - A-S Medication Solutions	A-S Medication Solutions	2019-01-24	HUMAN OTC DRUG LABEL	10